rs374905300
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_198576.4(AGRN):c.4967G>A(p.Arg1656Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000246 in 1,612,798 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1656W) has been classified as Likely benign.
Frequency
Consequence
NM_198576.4 missense
Scores
Clinical Significance
Conservation
Publications
- congenital myasthenic syndrome 8Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- presynaptic congenital myasthenic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- postsynaptic congenital myasthenic syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| AGRN | ENST00000379370.7 | c.4967G>A | p.Arg1656Gln | missense_variant | Exon 28 of 36 | 1 | NM_198576.4 | ENSP00000368678.2 | ||
| AGRN | ENST00000651234.1 | c.4652G>A | p.Arg1551Gln | missense_variant | Exon 27 of 38 | ENSP00000499046.1 | ||||
| AGRN | ENST00000652369.2 | c.4652G>A | p.Arg1551Gln | missense_variant | Exon 27 of 35 | ENSP00000498543.1 | ||||
| AGRN | ENST00000620552.4 | c.4553G>A | p.Arg1518Gln | missense_variant | Exon 28 of 39 | 5 | ENSP00000484607.1 | 
Frequencies
GnomAD3 genomes  0.000197  AC: 30AN: 151988Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.000105  AC: 26AN: 248796 AF XY:  0.000126   show subpopulations 
GnomAD4 exome  AF:  0.000251  AC: 367AN: 1460810Hom.:  0  Cov.: 34 AF XY:  0.000245  AC XY: 178AN XY: 726716 show subpopulations 
Age Distribution
GnomAD4 genome  0.000197  AC: 30AN: 151988Hom.:  0  Cov.: 32 AF XY:  0.000175  AC XY: 13AN XY: 74240 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases    Uncertain:1 
The c.4967G>A (p.R1656Q) alteration is located in exon 28 (coding exon 28) of the AGRN gene. This alteration results from a G to A substitution at nucleotide position 4967, causing the arginine (R) at amino acid position 1656 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided    Uncertain:1 
The c.4967 G>A variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The c.4967 G>A variant is observed in 13/65,078 (0.02%) alleles from individuals of European background (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). Multiple in-silico splice prediction models predict that c.4967 G>A creates a cryptic splice acceptor site which may supplant the natural acceptor site and lead to abnormal gene splicing. However, in the absence of RNA/functional studies the actual effect of c.4967 G>A on splicing in this individual is unknown. If c.4967 G>A does not alter splicing, it will result in the R1656Q missense change. The R1656Q variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. However, this substitution occurs at a position that is not conserved, and in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. -
Congenital myasthenic syndrome 8    Uncertain:1 
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1656 of the AGRN protein (p.Arg1656Gln). This variant is present in population databases (rs374905300, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with AGRN-related conditions. ClinVar contains an entry for this variant (Variation ID: 451650). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at